CD86 and neoplasm: Correlations between the upregulation of CD80, CD86, and CD28 have been found in OSCC [3], and the lack of change in CD28 and PD-1 transcripts in our tumor samples, which might have been associated with the complexity in CTLA4 abundancy [9,10], requires further stratification.